$47.5 Million in New Financing Secured from Existing Noteholders, Upsized from Initial $40 million Commitment Supports Mission to Continue Serving Life Sciences Researchers Worldwide SEATTLE / Feb 09, 2024 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into a credit agreement with its... Read More

Initiates Voluntary Chapter 11 Restructuring Proceedings with Additional $40 Million in Financing Secured from Existing Noteholders to Facilitate Process Continuing to Serve Life Sciences Researchers Worldwide SEATTLE / Feb 04, 2024 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced... Read More

Three customers will present inaugural studies powered by the novel CosMx Whole Transcriptome Panel during annual AGBT meeting SEATTLE / Feb 01, 2024 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel , the industry’s first single-cell spatial panel... Read More

Major milestone marked by first public dataset released for CosMx Whole Transcriptome Panel with additional data forthcoming at the AGBT Meeting SEATTLE / Jan 07, 2024 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell... Read More

SEATTLE / Jan 05, 2024 / Business Wire / NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 10 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on December 6, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors... Read More

SEATTLE / Jan 04, 2024 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 42 nd annual J.P. Morgan healthcare conference, being held January 8-11, 2024. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday,... Read More

SEATTLE / Nov 19, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17 th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profiler products infringe patents licensed to 10x Genomics and awarding approximately $31 million in... Read More

Twenty-two posters and two symposia to be offered at Neuroscience 2023 SEATTLE / Nov 09, 2023 / Business Wire / NanoString Technologies , a leading provider of life sciences tools for discovery and translational research, announced today it will present at the Society for Neuroscience (SfN) annual meeting a large body of new brain research powered by its industry-leading digital spatial profiling and spatial imaging... Read More

SEATTLE / Nov 09, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Stifel 2023 Healthcare Conference Tuesday, November 14th Tom Bailey, NanoString’s chief financial officer, and Doug Farrell, VP of Investor... Read More

Completed Exchange Transaction with Convertible Note Holders Representing 94% of Outstanding Principal Record Q3 Revenue of $48.1 Million, 63% Year on Year Growth and Above Upper End of Q3 Guidance Range SEATTLE / Nov 06, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter... Read More

Leading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas SEATTLE / Nov 01, 2023 / Business Wire / NanoString Technologies , a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at the 38 th annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held in... Read More

Record Q3 Revenue of Over $48 Million, 63% Year on Year Growth, Above Upper End of Q3 Guidance Range Implementing Reorganization of R&D and Manufacturing Operations to Improve Path to Profitability SEATTLE / Oct 10, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational... Read More

SINGAPORE / Oct 03, 2023 / Business Wire / A*STAR’s Genome Institute of Singapore (GIS), NanoString ® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint laboratory in Singapore focusing on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response. The new lab, called the SpACE-Dx lab ( S patial A tlas of C... Read More

NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in Europe SEATTLE / Sep 19, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on today’s order from the... Read More

Fifth annual event will explore the latest advancements in spatial biology highlighting new products and customer success stories SEATTLE / Sep 14, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced it will host its fifth annual Spatial Genomics Summit , September 19 th . The two-hour virtual event will showcase... Read More

Empowering researchers to spatially profile more than 500 proteins simultaneously in FFPE tissue using abcam’s IHC-validated immuno-oncology antibody portfolio SEATTLE / Sep 13, 2023 / Business Wire / NanoString Technologies (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for the GeoMx® Digital Spatial Profiler (DSP). The GeoMx... Read More

Macrogen, Inc., Propath UK, and Sirona Dx Add CosMx Spatial Molecular Imager to Meet Growing Demand for Spatial Biology Tools for Drug Developers SEATTLE / Sep 07, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today three new Contract Research Organization (CRO) CosMx TM Spatial Molecular Imager partnerships.... Read More

SEATTLE / Sep 05, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences. Morgan Stanley 21 st Annual Global Heathcare Conference Tuesday, September 12th Brad Gray, NanoString’s chief executive officer, will... Read More

August Issue of Lancet Medical Journal Features Breakthrough Study Decoding Immunological Challenges of Xenotransplantation SEATTLE / Aug 21, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today that a team of globally renowned researchers utilized two NanoString platforms, the nCounter® Analysis System and... Read More

Record Q2 Revenue of $44.2 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range Retained More than $35 Million in CosMx Instrument Order Backlog at the End of Q2 SEATTLE / Aug 03, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June 30, 2023.... Read More

10x and Harvard now must defend against allegations that they “are pursuing an ill-gotten monopoly by enforcing patents that are subject to a requirement that they be licensed non-exclusively” SEATTLE / Jul 11, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United States... Read More

Record Q2 Revenue of Over $44 Million, 37% Year on Year Growth and Above Upper End of Q2 Guidance Range New Orders for CosMx Instruments Grew Sequentially and Year on Year SEATTLE / Jul 10, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter... Read More

SEATTLE / Jun 30, 2023 / Business Wire / NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on June 27, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors... Read More

SEATTLE / Jun 09, 2023 / Business Wire / NanoString Technologies, Inc. ( Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on June 6, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors... Read More

FOSTER CITY, Calif. / Jun 08, 2023 / Business Wire / Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung... Read More

Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments Landmark research project is 100x larger than existing efforts Data will be generated from thousands of patients across multiple cancers University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum... Read More

SEATTLE / May 31, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the Jefferies Healthcare Conference, which will be held June 7-9, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Thursday, June 8, 2023, at... Read More

SEATTLE / May 22, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will host a conference call on Monday, May 22, 2023, at 4:30pm ET to provide an update on the recent Decision of the Regional Court of Munich. Investors and other interested parties should register for the conference call in... Read More

SEATTLE & MUNICH / May 17, 2023 / Business Wire / NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today responded to the Regional Court of Munich’s recent decision finding that NanoString’s CosMx Spatial Molecular Imager, when used to detect RNA targets, infringes the German part of the European patent 2794928B1. The Munich court granted 10x... Read More

Q1 Revenue of $35.8 Million Total Spatial Biology and nCounter Revenue Above Upper End of Q1 Guidance Ranges Raising Annual Revenue Guidance to $175-185 Million SEATTLE / May 03, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter ended March 31, 2023. “2023 is off to a... Read More

SEATTLE / Apr 10, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business... Read More

SEATTLE / Mar 08, 2023 / Business Wire / NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 16 new employees. In accordance with Nasdaq Listing Rule 5635(c)(4), on March 4, 2023, the Compensation and Human Capital Committee of NanoString’s Board of Directors... Read More

SEATTLE / Feb 06, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL. The Company is hosting the Gold Sponsor workshop... Read More

First comprehensive spatial atlas of healthy human tissue from multiple organs, including multi-cell and single cell resolution using both GeoMx and CosMx SEATTLE / Feb 02, 2023 / Business Wire / NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced the launch of the Spatial Atlas of Human Anatomy (SAHA) initiative, in collaboration with... Read More

New liver tissue dataset highlights high sensitivity and specificity of CosMx system, and the biological power of spatially analyzing 1000 RNA targets NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new data generated by the CosMx™ Spatial Molecular Imager (SMI). This data was generated from formalin-fixed... Read More

Generated Record Orders for Over 105 Spatial Biology Instruments in Q4, Representing 50% Growth Year-over-Year Q4 Product and Service Revenue of Over $34 Million, Within Guidance Range of $33 to $35 Million NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and... Read More

Spatial Molecular Imager Locates Rare Senescent Cells in Brain Tissue NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s CosMx™ Spatial Molecular Imager (SMI) has been highlighted in the January edition of National... Read More

NanoString Technologies, Inc . (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, January 11th, 2023, at 3:00pm PT. Interested parties can access the live webcast with... Read More